4 Results for "

ATR-Chk1

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "ATR-Chk1" in MCE Product Catalog:

Cat. No.: HY-164496
CAS No.: 1161826-19-2
Target:  

DNA/RNA Synthesis

Research Areas:  

Neurological Disease Cancer

KL-50 is an orally active N3-(2-fluoroethyl) imidazotetrazine DNA alkylating agent with selectivity for MGMT-deficient cells. KL-50 introduces a 2-fluoroethyl group at the O6 position of guanine, forming O6-(2-fluoroethyl) guanine (O6FEtG) lesions and further generating DNA interstrand crosslinks (ICLs). KL-50 induces DNA double-strand breaks, activates ATR-CHK1 and ATM-CHK2 DNA damage responses, and causes cell cycle arrest and micronucleus formation. KL-50 can be used for glioblastoma and DNA damage response research [1] .
loading...
    loading...
Cat. No.: HY-147021
CAS No.: 1350456-66-4
Target:  

ADC Linkers

Research Areas:  

Cancer

MC-Val-D-Cit-PAB-PNP is a peptide linker that can be used for the synthesis of Antibody-Drug Conjugates (ADCs). MC-Val-D-Cit-PAB-PNP can be used to construct antibody-drug conjugates loaded with ATR/CHK1 inhibitors [1].
loading...
    loading...
Cat. No.: HY-147021A
CAS No.: 1350456-64-2
Target:  

ADC Linkers

Research Areas:  

Cancer

MC-D-Val-Cit-PAB-PNP is a peptide linker that can be used for the synthesis of Antibody-Drug Conjugates (ADCs). MC-D-Val-Cit-PAB-PNP can be used to construct antibody-drug conjugates loaded with ATR/CHK1 inhibitors [1].
loading...
    loading...
Cat. No.: HY-149213
CAS No.: 4734-59-2
Purity:  99.20%
Synonyms: J54; J3-54
Research Areas:  

Cancer

LSD1/TLK1-IN-1 is an orally active LSD1, TLK1, TLK2, TTK inhibitor with an LSD1 IC50 of 0.247 μM. LSD1/TLK1-IN-1 suppresses phosphorylation of Nek1 at T141 and Rad9 at S328, abrogates the TLK1>Nek1>ATR>Chk1 axis, protects H3K4me1/2 from demethylation, and does not affect LSD2, MAO-A, or MAO-B. LSD1/TLK1-IN-1 induces apoptosis, bypasses cell-cycle arrest, suppresses tumor growth, downregulates PD-L1 expression, enhances T-cell killing response, inhibits gastric cancer cell proliferation. LSD1/TLK1-IN-1 can be used for the research of prostate cancer and gastric cancer [1] .
loading...
    loading...